| 3LC5: reference: Structure Based Drug Design: Development of Potent and Selective Factor IXa (FIXa) Inhibitors., Wang S, Beck R, Burd A, Blench T, Marlin F, Ayele T, Buxton S, Dagostin C, Malic M, Joshi R, Barry J, Sajad M, Cheung C, Shaikh S, Chahwala S, Chander C, Baumgartner C, Holthoff HP, Murray E, Blackney M, Giddings A, J Med Chem. 2010 Feb 25;53(4):1473-82. PMID: 20121197 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).